FAIR LAWN, N.J.--(BUSINESS WIRE)--Vyteris, Inc. (OTCBB: VYHN), manufacturer of the first FDA-approved active patch transdermal drug delivery system, discussed the appointments of Haro Hartounian as president and Joseph Himy as chief financial officer to lead the company in its pursuit of several strategic initiatives for collaborative development and licensing of its patented-technology.
